Mounjaro® is an FDA-approved prescription medication that contains tirzepatide, a dual GIP and GLP-1 receptor agonist approved for the treatment of type 2 diabetes and widely prescribed off-label for weight management.
Compounded Mounjaro® contains the same active ingredient—tirzepatide—and is prepared by licensed compounding pharmacies based on a doctor’s prescription. Compounding allows treatment to be personalized to a patient’s needs when commercially available options may not be suitable or accessible.
While Mounjaro® itself is FDA-approved, compounded versions are not individually FDA-approved finished products. They are legally prepared by licensed pharmacies under strict regulatory standards and quality controls.
This medication is not a substitute for insulin and is not approved for use in patients with type 1 diabetes or diabetic ketoacidosis.
Do not use this medication if you:
Consult your doctor if you are unsure about your medical history or current health conditions.
Mounjaro® is taken as a once-weekly injection under the skin of the abdomen, thigh, or upper arm.
Most patients start at a lower dose, which is gradually increased over time to help reduce side effects and allow the body to adjust. Your exact dose and treatment plan will be determined by your &you-assigned doctor.
If you miss a dose:
Storage: Keep refrigerated unless otherwise instructed.
Disposal: Used needles should be disposed of in an approved sharps container.
Before starting Mounjaro®, inform your doctor if you:
Providing complete medical information helps ensure your treatment is safe and appropriate.
Although uncommon, serious side effects may occur. Seek medical attention immediately if you experience:
The most commonly reported side effects of Mounjaro® include:
These side effects are usually mild to moderate and tend to improve as your body adjusts, especially when doses are increased gradually.
Mounjaro® is intended to support metabolic health and weight management as part of a broader treatment plan that includes nutrition and lifestyle changes. It is not a cure for obesity or metabolic disease.
For safe use:
To report side effects in the Philippines, contact the Philippine Food and Drug Administration (FDA) through their Adverse Drug Reaction (ADR) Reporting System or call +63 2-8809-5596.
For full prescribing information and additional details, visit the Philippine FDA website.
.avif&w=256&q=75){kind=logo}